There’s been a lot
of change in our community this year, but perhaps none so impactful as the
change in Baxalta, now a part of Shire. Please read below to learn more about
these changes, and click through to learn how Shire will keep on serving you!

Shire, is built on
strength and experience, and is powered by an enduring commitment to you. Each
company brings world-class products, as well as, a foundation for sustained
category leadership in rare diseases.

Combining 60 years
with 30 years of dedicated history to bleeding and rare disorders communities,
the new company has even more resources to offer. What that means for patients
is that Shire is maintaining its solid commitment to you while still offering
innovative products. Introducing new treatments for bleeding disorders, and
making a meaningful difference in the lives of patients and families continues
to be Shire’s main focus.

Shire’s combined
product offerings have expanded the range of therapeutic areas. Shire and
Baxalta are combining 30 years with 60 years of dedicated history to the rare
disease and hematology community. Together they are commitment to the
hematology community.

To learn more visit http://www.baxaltahematology.com/us/.

This is a paid announcement by Baxalta, now part of Shire.

August 2016

USBS/MG1/16-0527a